연구동향 분석

Molecular Identification and Amphotericin B Susceptibility Testing of Clinical Isolates of Aspergillus From 11 Hospitals in Korea

허민석 신종희 최민지 박연준 이혜수 구선회 이원길 김수현 신명근 서순팔 양동욱 2015년

논문상세정보
인용/피인용
' Molecular Identification and Amphotericin B Susceptibility Testing of Clinical Isolates of Aspergillus From 11 Hospitals in Korea' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 의학
  • amphotericin b
  • aspergillus
  • clsi
  • etest
  • identification
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
7,962 0

0.0%

' Molecular Identification and Amphotericin B Susceptibility Testing of Clinical Isolates of Aspergillus From 11 Hospitals in Korea' 의 참고문헌

  • Wild-type MIC distributions and epidemiological cutoff values for amphotericin B and Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document)
    Espinel-Ingroff A Antimicrob Agents Chemother 55 : 5150 ~ 5154 [2011]
  • Wild-type MIC distributions and epidemiological cutoff values for amphotericin B and Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document)
    Espinel-Ingroff A Antimicrob Agents Chemother 55 5150-5154 [2011]
  • Update on antifungal resistance in Aspergillus and Candida
    Arendrup MC Clin Microbiol Infect 20 : S42 ~ 48 [2014]
  • Update on antifungal resistance in Aspergillus and Candida
    Arendrup MC Clin Microbiol Infect 20 S42-48 [2014]
  • Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved standard, 2nd ed. M38-A2
    Clinical and Laboratory Standards Institute Clinical and Laboratory Standards Institute [2008]
  • Molecular studies reveal frequent misidentification of Aspergillus fumigatus by morphotyping
    Balajee SA Eukaryot Cell 5 : 1705 ~ 1712 [2006]
  • Molecular studies reveal frequent misidentification of Aspergillus fumigatus by morphotyping
    Balajee SA Eukaryot Cell 5 1705-1712 [2006]
  • Molecular identification of Aspergillus species collected for the Transplant-Associated Infection Surveillance Network
    Balajee SA J Clin Microbiol 47 : 3138 ~ 3141 [2009]
  • Molecular identification of Aspergillus species collected for the Transplant-Associated Infection Surveillance Network
    Balajee SA J Clin Microbiol 47 3138-3141 [2009]
  • Molecular identification and antifungal susceptibility profile of Aspergillus flavus isolates recovered from clinical specimens in Kuwait
    Al-Wathiqi F BMC Infect Dis 13 : 126 ~ [2013]
  • Molecular identification and antifungal susceptibility profile of Aspergillus flavus isolates recovered from clinical specimens in Kuwait
    Al-Wathiqi F BMC Infect Dis 13 126- [2013]
  • Mistaken identity: Neosartorya pseudofischeri and its anamorph masquerading as Aspergillus fumigatus
    Balajee SA J Clin Microbiol 43 : 5996 ~ 5999 [2005]
  • Mistaken identity: Neosartorya pseudofischeri and its anamorph masquerading as Aspergillus fumigatus
    Balajee SA J Clin Microbiol 43 5996-5999 [2005]
  • In-vitro testing of susceptibility to amphotericin B is a reliable predictor of clinical outcome in invasive aspergillosis
    Lass-Flörl C J Antimicrob Chemother 42 : 497 ~ 502 [1998]
  • In-vitro testing of susceptibility to amphotericin B is a reliable predictor of clinical outcome in invasive aspergillosis
    Lass-Flörl C J Antimicrob Chemother 42 497-502 [1998]
  • In vitro activity of a new oral glucan synthase inhibitor (MK-3118) tested against Aspergillus spp. by CLSI and EUCAST broth microdilution methods
    Pfaller MA Antimicrob Agents Chemother 57 : 1065 ~ 1068 [2013]
  • In vitro activity of a new oral glucan synthase inhibitor (MK-3118) tested against Aspergillus spp. by CLSI and EUCAST broth microdilution methods
    Pfaller MA Antimicrob Agents Chemother 57 1065-1068 [2013]
  • In vitro activities of various antifungal drugs against Aspergillus terreus: global assessment using the methodology of the European committee on antimicrobial susceptibility testing
    Lass-Flörl C Antimicrob Agents Chemother 53 : 794 ~ 795 [2009]
  • In vitro activities of various antifungal drugs against Aspergillus terreus: global assessment using the methodology of the European committee on antimicrobial susceptibility testing
    Lass-Flörl C Antimicrob Agents Chemother 53 794-795 [2009]
  • In vitro activities of amphotericin B and AmBisome against Aspergillus isolates recovered from Italian patients treated for haematological malignancies
    Colozza C Int J Antimicrob Agents 39 : 440 ~ 443 [2012]
  • In vitro activities of amphotericin B and AmBisome against Aspergillus isolates recovered from Italian patients treated for haematological malignancies
    Colozza C Int J Antimicrob Agents 39 440-443 [2012]
  • European Committee on Antimicrobial Susceptibility Testing Subcommittee on Antifungal Susceptibility Testing (EUCAST-AFST). EUCAST technical note on Aspergillus and amphotericin B, itraconazole, and posaconazole
    Arendrup MC Clin Microbiol Infect 18 : E248 ~ 250 [2012]
  • European Committee on Antimicrobial Susceptibility Testing Subcommittee on Antifungal Susceptibility Testing (EUCAST-AFST). EUCAST technical note on Aspergillus and amphotericin B, itraconazole, and posaconazole
    Arendrup MC Clin Microbiol Infect 18 E248-250 [2012]
  • Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience
    Lass-Flörl C Br J Haematol 131 : 201 ~ 207 [2005]
  • Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience
    Lass-Flörl C Br J Haematol 131 201-207 [2005]
  • Effects of amphotericin B on Aspergillus flavus clinical isolates with variable susceptibilities to the polyene in an experimental model of systemic aspergillosis
    Barchiesi F J Antimicrob Chemother 68 : 2587 ~ 2591 [2013]
  • Effects of amphotericin B on Aspergillus flavus clinical isolates with variable susceptibilities to the polyene in an experimental model of systemic aspergillosis
    Barchiesi F J Antimicrob Chemother 68 2587-2591 [2013]
  • Detection of amphotericin B resistance in Candida haemulonii and closely related species by use of the Etest, Vitek-2 yeast susceptibility system, and CLSI and EUCAST broth microdilution methods
    Shin JH J Clin Microbiol 50 : 1852 ~ 1855 [2012]
  • Detection of amphotericin B resistance in Candida haemulonii and closely related species by use of the Etest, Vitek-2 yeast susceptibility system, and CLSI and EUCAST broth microdilution methods
    Shin JH J Clin Microbiol 50 1852-1855 [2012]
  • Current section and species complex concepts in Aspergillus: recommendations for routine daily practice
    Alastruey-Izquierdo A Ann N Y Acad Sci 1273 : 18 ~ 24 [2012]
  • Current section and species complex concepts in Aspergillus: recommendations for routine daily practice
    Alastruey-Izquierdo A Ann N Y Acad Sci 1273 18-24 [2012]
  • Comparison of the Etest and the sensititre colorimetric methods with the NCCLS proposed standard for antifungal susceptibility testing of Aspergillus species
    Meletiadis J J Clin Microbiol 40 : 2876 ~ 2885 [2002]
  • Comparison of the Etest and the sensititre colorimetric methods with the NCCLS proposed standard for antifungal susceptibility testing of Aspergillus species
    Meletiadis J J Clin Microbiol 40 2876-2885 [2002]
  • Comparison of disk diffusion, E-test and broth microdilution test in determination of susceptibility of Aspergillus species to amphotericin B, itraconazole and voriconazole
    Ozkutuk A J Chemother 20 : 87 ~ 92 [2008]
  • Comparison of disk diffusion, E-test and broth microdilution test in determination of susceptibility of Aspergillus species to amphotericin B, itraconazole and voriconazole
    Ozkutuk A J Chemother 20 87-92 [2008]
  • Comparison of E-test and broth microdilution methods for antifungal drug susceptibility testing of molds
    Szekely A J Clin Microbiol 37 : 1480 ~ 1483 [1999]
  • Comparison of E-test and broth microdilution methods for antifungal drug susceptibility testing of molds
    Szekely A J Clin Microbiol 37 1480-1483 [1999]
  • Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry
    Steinbach WJ J Infect 65 : 453 ~ 464 [2012]
  • Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry
    Steinbach WJ J Infect 65 453-464 [2012]
  • Candida haemulonii and closely related species at 5 university hospitals in Korea: identification, antifungal susceptibility, and clinical features
    Kim MN Clin Infect Dis 48 : e57 ~ 61 [2009]
  • Candida haemulonii and closely related species at 5 university hospitals in Korea: identification, antifungal susceptibility, and clinical features
    Kim MN Clin Infect Dis 48 e57-61 [2009]
  • Aspergillus species intrinsically resistant to antifungal agents
    Van Der Linden JW Med Mycol 49 : S82 ~ 89 [2011]
  • Aspergillus species intrinsically resistant to antifungal agents
    Van Der Linden JW Med Mycol 49 S82-89 [2011]
  • Aspergillus species identification in the clinical setting
    Balajee SA Stud Mycol 59 : 39 ~ 46 [2007]
  • Aspergillus species identification in the clinical setting
    Balajee SA Stud Mycol 59 39-46 [2007]
  • Aspergillus niger contains the cryptic phylogenetic species A. awamori
    Perrone G Fungal Biol 115 : 1138 ~ 1150 [2011]
  • Aspergillus niger contains the cryptic phylogenetic species A. awamori
    Perrone G Fungal Biol 115 1138-1150 [2011]
  • Antifungal susceptibility of the aspergillus species by Etest and CLSI reference methods
    Badiee P Arch Iran Med 15 : 429 ~ 432 [2012]
  • Antifungal susceptibility of the aspergillus species by Etest and CLSI reference methods
    Badiee P Arch Iran Med 15 429-432 [2012]